165 related articles for article (PubMed ID: 32140744)
1. Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity.
Jall S; De Angelis M; Lundsgaard AM; Fritzen AM; Nicolaisen TS; Klein AB; Novikoff A; Sachs S; Richter EA; Kiens B; Schramm KW; Tschöp MH; Stemmer K; Clemmensen C; Müller TD; Kleinert M
Diabetologia; 2020 Jun; 63(6):1236-1247. PubMed ID: 32140744
[TBL] [Abstract][Full Text] [Related]
2. Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes.
Clemmensen C; Jall S; Kleinert M; Quarta C; Gruber T; Reber J; Sachs S; Fischer K; Feuchtinger A; Karlas A; Simonds SE; Grandl G; Loher D; Sanchez-Quant E; Keipert S; Jastroch M; Hofmann SM; Nascimento EBM; Schrauwen P; Ntziachristos V; Cowley MA; Finan B; Müller TD; Tschöp MH
Nat Commun; 2018 Oct; 9(1):4304. PubMed ID: 30353008
[TBL] [Abstract][Full Text] [Related]
3. Nicotinic acetylcholine receptors in glucose homeostasis: the acute hyperglycemic and chronic insulin-sensitive effects of nicotine suggest dual opposing roles of the receptors in male mice.
Vu CU; Siddiqui JA; Wadensweiler P; Gayen JR; Avolio E; Bandyopadhyay GK; Biswas N; Chi NW; O'Connor DT; Mahata SK
Endocrinology; 2014 Oct; 155(10):3793-805. PubMed ID: 25051446
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity.
Kalinovich A; Dehvari N; Åslund A; van Beek S; Halleskog C; Olsen J; Forsberg E; Zacharewicz E; Schaart G; Rinde M; Sandström A; Berlin R; Östenson CG; Hoeks J; Bengtsson T
Diabetologia; 2020 Aug; 63(8):1603-1615. PubMed ID: 32472192
[TBL] [Abstract][Full Text] [Related]
5. Prolonged β
van Beek SMM; Kalinovich A; Schaart G; Bengtsson T; Hoeks J
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E619-E628. PubMed ID: 33522400
[TBL] [Abstract][Full Text] [Related]
6. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
Rao TS; Correa LD; Lloyd GK
Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640
[TBL] [Abstract][Full Text] [Related]
7. Carrier-mediated release of monoamines induced by the nicotinic acetylcholine receptor agonist DMPP.
Szász BK; Mayer A; Zsilla G; Lendvai B; Vizi ES; Kiss JP
Neuropharmacology; 2005 Sep; 49(3):400-9. PubMed ID: 15993437
[TBL] [Abstract][Full Text] [Related]
8. Nifedipine inhibits adrenal but not circulating catecholamine response to nicotinic stimulation in dogs.
Gaspo R; Yamaguchi N; de Champlain J
Am J Physiol; 1994 Dec; 267(6 Pt 2):R1545-51. PubMed ID: 7810764
[TBL] [Abstract][Full Text] [Related]
9. Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse.
Fischer H; Orr-Urtreger A; Role LW; Huck S
J Physiol; 2005 Feb; 563(Pt 1):119-37. PubMed ID: 15611037
[TBL] [Abstract][Full Text] [Related]
10. Decrement in resting and insulin-stimulated soleus muscle mitochondrial respiration is an early event in diet-induced obesity in mice.
Brunetta HS; de Paula GC; de Oliveira J; Martins EL; Dos Santos GJ; Galina A; Rafacho A; de Bem AF; Nunes EA
Exp Physiol; 2019 Mar; 104(3):306-321. PubMed ID: 30578638
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
[TBL] [Abstract][Full Text] [Related]
12. Noncompetitive inhibition by camphor of nicotinic acetylcholine receptors.
Park TJ; Seo HK; Kang BJ; Kim KT
Biochem Pharmacol; 2001 Apr; 61(7):787-93. PubMed ID: 11274963
[TBL] [Abstract][Full Text] [Related]
13. Insulin and glucagon secretion by ganglionic nicotinic activation in adrenalectomized mice.
Karlsson S; Ahrén B
Eur J Pharmacol; 1998 Jan; 342(2-3):291-5. PubMed ID: 9548399
[TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
Xu TY; Guo LL; Wang P; Song J; Le YY; Viollet B; Miao CY
PLoS One; 2012; 7(12):e51217. PubMed ID: 23251458
[TBL] [Abstract][Full Text] [Related]
15. Effects on serotonin of (-)nicotine and dimethylphenylpiperazinium in the dorsal raphe and nucleus accumbens of freely behaving rats.
Ma Z; Strecker RE; McKenna JT; Thakkar MM; McCarley RW; Tao R
Neuroscience; 2005; 135(3):949-58. PubMed ID: 16154286
[TBL] [Abstract][Full Text] [Related]
16. Phytoestrogen cimicifugoside-mediated inhibition of catecholamine secretion by blocking nicotinic acetylcholine receptor in bovine adrenal chromaffin cells.
Woo KC; Park YS; Jun DJ; Lim JO; Baek WY; Suh BS; Kim KT
J Pharmacol Exp Ther; 2004 May; 309(2):641-9. PubMed ID: 14757852
[TBL] [Abstract][Full Text] [Related]
17. Allosteric interaction of the anticholinergic drug [N-(4-phenyl)-phenacyl-l-hyoscyamine] (Phenthonium) with nicotinic receptors of post-ganglionic sympathetic neurons of the rat vas deferens.
Munhoz E; De Lima TC; Souccar C; Lapa AJ; Lima-Landman MT
Eur J Pharmacol; 2009 Aug; 616(1-3):229-35. PubMed ID: 19540221
[TBL] [Abstract][Full Text] [Related]
18. Protein synthesis blockade differentially affects the degradation of constitutive and nicotinic receptor-induced tyrosine hydroxylase protein level in isolated bovine chromaffin cells.
Fernández E; Craviso GL
J Neurochem; 1999 Jul; 73(1):169-78. PubMed ID: 10386968
[TBL] [Abstract][Full Text] [Related]
19. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release.
Ohtani M; Oka T; Badyuk M; Xiao Y; Kellar KJ; Daly JW
Mol Pharmacol; 2006 Mar; 69(3):899-907. PubMed ID: 16332988
[TBL] [Abstract][Full Text] [Related]
20. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance.
Wang X; Yang Z; Xue B; Shi H
Endocrinology; 2011 Mar; 152(3):836-46. PubMed ID: 21239433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
